6,220 results on '"GLIOMAS"'
Search Results
2. Study Data from University of Milan Update Knowledge of Gliomas (V-ATPase in glioma stem cells: a novel metabolic vulnerability)
3. 'Scalable Biomanufacturing Of Tumor Organoids' in Patent Application Approval Process (USPTO 20250019665)
4. TGFBR2-High mesenchymal glioma stem cells phenocopy regulatory T cells to suppress CD4+ and CD8+ T cell function
5. New Gliomas Data Have Been Reported by Investigators at Zhejiang Normal University (Mechanism and Effects of Multiscale Pulsed Electromagnetic Fields On Rat Glioma Cells)
6. Combined inhibition of SHP2 overcomes adaptive resistance to type 1 BRAF inhibitors in BRAF V600E-driven high-grade glioma
7. The oncometabolite D-2-hydroxyglutarate promotes DNA hypermethylation at lineage-specific enhancers controlling microglial activation in IDHmut gliomas (Updated December 17, 2024)
8. Researcher at National Institutes of Health (NIH) Publishes Research in Gliomas (A scoping review of Diffuse Hemispheric Glioma, H3 G34-mutant: epigenetic and molecular profiles, clinicopathology, and treatment avenues)
9. New Gliomas Data Have Been Reported by Researchers at Boston College (Amino Acid and Glucose Fermentation Maintain Atp Content In Mouse and Human Malignant Glioma Cells)
10. Findings from Virginia Polytechnic Institute and State University (Virginia Tech) Update Knowledge of Gliomas (A Photopolymerizable Hyaluronic Acid-collagen Model of the Invasive Glioma Microenvironment With Interstitial Flow)
11. Reports from University of Udine Advance Knowledge in Gliomas (Glioma-Derived Exosomes and Their Application as Drug Nanoparticles)
12. Clinical and Molecular Characterization of Glioma Patients: miR-21 Expression as a Prognostic Biomarker in Tissue and Serum
13. The oncometabolite D-2-hydroxyglutarate promotes DNA hypermethylation at lineage-specific enhancers controlling microglial activation in IDHmut gliomas (Updated November 8, 2024)
14. Researchers at Shandong Normal University Have Reported New Data on Gliomas (Recent Advances In Spatio-temporally Controllable Systems for Management of Glioma)
15. New Gliomas Study Findings Recently Were Reported by Researchers at National Cancer Institute (NCI) (myb/mybl1-altered Gliomas Frequently Harbor Truncations and Non-productive Fusions In the myb an
16. Inhibition of H3K27M-enhanced ATM signaling increases radiation efficacy in diffuse midline glioma
17. Aberrant FGF signaling promotes granule neuron precursor expansion in SHH subgroup infantile medulloblastoma (Updated November 4, 2024)
18. Reports from Department of Medical Physics Advance Knowledge in Gliomas (Temozolomide Overdose In Treating High-grade Glioma: a Case Report)
19. Exploring N6-Methyladenosine and long transcripts in glioma cells and extracellular vesicles
20. Studies from Walter and Eliza Hall Institute of Medical Research Provide New Data on Gliomas (Evolving Practice and Outcomes in Grade 2 Glioma: Real-World Data from a Multi-Institutional Registry)
21. Differential expression of GABARAPs in GBM renders temozolomide sensitivity in a p53-dependent manner
22. Deficiency of Hv1 Proton Channel Enhances Macrophage Antigen Presentation and Anti-Tumor Responses in Glioma
23. Data from University of Michigan Update Knowledge in Gliomas (Therapeutic targeting of differentiation-state dependent metabolic vulnerabilities in diffuse midline glioma)
24. New Gliomas Study Findings Reported from Bucharest (High-Grade Thalamic Glioma: Case Report with Literature Review)
25. Onco-fetal protein Nogo-A restricts human and mouse glioma vascularization and growth via VEGF-Notch-hippo-metabolic signaling
26. New Gliomas Findings from Institute of Nano Science and Technology Described (Unravelling the Potential of <sc>l</sc>-carnosine Analog-based Nano-assemblies As Ph-responsive Therapeutics In Treating Glioma: an in Vitro Pers
27. Combination of Imipridone ONC201 or ONC206 with Temozolomide and Radiotherapy in triple ITR therapy reduces intracranial tumor burden and prolongs survival in an orthotopic wild-type IDH GBM mouse model
28. Investigators at QIMR Berghofer Medical Research Institute Discuss Findings in Gliomas (Tools To Study Neural and Glioma Stem Cell Quiescence)
29. Cholinergic Neuronal Activity Promotes Diffuse Midline Glioma Growth through Muscarinic Signaling (Updated September 24, 2024)
30. Aquaporin-4 expression levels and mis-localization are inversely linked to peritumoral edema in gliomas of varying aggressiveness
31. Amino Acid and Glucose Fermentation Maintain ATP Content in Mouse and Human Malignant Glioma Cells (Updated September 21, 2024)
32. Patent Issued for Suicide gene therapeutic agent for brain tumors using pluripotent stem cell (USPTO 12090172)
33. PPM1D truncation-associated overexpression of the stress-related protein NQO1 confers sensitivity to the bioactivatable drug IB-DNQ in diffuse intrinsic pontine glioma
34. Methylsulfonylmethane: A Potential Dietary Supplement targeting sphingosine kinase 1 involved in Glioblastomamultiforme
35. The oncometabolite D-2-hydroxyglutarate promotes DNA hypermethylation at lineage-specific enhancers controlling microglial activation in IDHmut gliomas
36. H3K27M diffuse midline glioma is homologous recombination defective and sensitized to radiotherapy and NK cell-mediated antitumor immunity by PARP inhibition
37. New Gliomas Study Findings Reported from Nanjing Medical University (Adt-unet: an Innovative Algorithm for Glioma Segmentation In Mr Images)
38. New Gliomas Findings from Harbin Medical University Discussed (Dose-painting Proton Radiotherapy Guided By Functional Mri In Non-enhancing High-grade Gliomas)
39. Data from Massachusetts General Hospital Update Knowledge in Gliomas (Clinical utility of a blood based assay for the detection of IDH1.R132H-mutant gliomas)
40. Department of Photomedicine and Physical Chemistry Researcher Targets Gliomas (Molecular Determinants for Photodynamic Therapy Resistance and Improved Photosensitizer Delivery in Glioma)
41. The splicing modulator CLK1 is a candidate oncogenic dependency in pediatric high-grade gliomas
42. Recent Findings in Gliomas Described by a Researcher from University of Virginia (Neurosteroids in Glioma: A Novel Therapeutic Concept)
43. Findings from Shengjing Hospital of China Medical University Provide New Insights into Gliomas (M6A-methylated circPOLR2B forms an R-loop and regulates the biological behavior of glioma stem cells through positive feedback loops)
44. Augusta University Researcher Publishes New Data on Gliomas (Clinical Utility of Optical Genome Mapping for Improved Cytogenomic Analysis of Gliomas)
45. Aberrant FGF signaling promotes granule neuron precursor expansion in SHH subgroup infantile medulloblastoma (Updated July 27, 2024)
46. Dartmouth College Geisel School of Medicine Researcher Reports Recent Findings in Drugs and Therapies (Chemical genetic screens reveal defective lysosomal trafficking as synthetic lethal with NF1 loss)
47. Studies from Newcastle University Further Understanding of Gliomas (Dipg-88. Targeting The Antioxidant Response Element Axis Sensitizes Diffuse Midline Glioma Cells To Onc201)
48. Sanford Burnham Prebys Medical Discovery Institute Researcher Adds New Findings in the Area of Xenografts (Stem-07. Conservation And Faithful Representation of Circular Extrachromosomal Dna in Orthotopic Patient-derived Medulloblastoma ...)
49. Department of Pediatric Oncology Researcher Describes Recent Advances in Gliomas (Dipg-14. Metabolic Reprogramming As A Resistance Mechanism in Diffuse Midline Glioma)
50. Columbia University Irving Medical Center Researcher Focuses on Gliomas (Dipg-41. Convection Enhanced Delivery-mediated Radiosensitization For Diffuse Midline Glioma)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.